ID   BRG-P
AC   CVCL_W880
DR   Wikidata; Q54798230
RX   PubMed=8207254;
RX   PubMed=8695808;
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Donor information: Established from a HIV-1 infected patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 10
//
RX   PubMed=8207254; DOI=10.4049/jimmunol.153.1.45;
RA   Jain R., Roncella S., Hashimoto S., Carbone A., Francia di Celle P.,
RA   Foa R., Ferrarini M., Chiorazzi N.;
RT   "A potential role for antigen selection in the clonal evolution of
RT   Burkitt's lymphoma.";
RL   J. Immunol. 153:45-52(1994).
//
RX   PubMed=8695808; DOI=10.1182/blood.V88.2.599.bloodjournal882599;
RA   Roncella S., Cutrona G., Favre A., Ulivi M., Fais F., Signorini A.,
RA   Grossi C.E., Chiorazzi N., Ferrarini M.;
RT   "Apoptosis of Burkitt's lymphoma cells induced by specific interaction
RT   of surface IgM with a self-antigen: implications for lymphomagenesis
RT   in acquired immunodeficiency syndrome.";
RL   Blood 88:599-608(1996).
//